In-Depth With CDRH Compliance Chief: Jan Welch Trumpets 'Case For Quality,' Urges Feedback From Manufacturers
This article was originally published in The Gray Sheet
This "Silver Sheet"/"Gray Sheet" Q&A with Jan Welch, interim director of CDRH's Office of Compliance, offers a glimpse into current device center thinking on various activities such as FDA's "Case for Quality." She also warns device manufacturers that if they don't speak up, some issues of importance to them could end up on the back burner. And: Is Welch interested in the job full time?
You may also be interested in...
Device Week, 4 December 2020 – MedWatch Question About Third-Party Servicers Slides Under Industry's Radar
On this week’s podcast: A change made by the US FDA to its MedWatch program that asks adverse event reporters whether a third party serviced a malfunctioning medical device went unnoticed by many in industry for nearly a year. We explain why, and tell how the servicer question will be helpful for manufacturers and the agency.
The proposed rule from the US HHS that would require its agencies to review all regulations every 10 years could distract an incoming Biden administration from the COVID-19 pandemic and will “wreak havoc” on Medicare, a senior policy analyst for the Center on Budget and Policy Priorities says.
The US agency says in the latest update to its medical device shortages guidance doc that it’ll send enforcement missives to companies that don’t notify the agency of a “permanent discontinuance or an interruption in manufacturing” of products deemed critical during the COVID-19 pandemic.